Correlation Between Embecta Corp and Rapport Therapeutics
Can any of the company-specific risk be diversified away by investing in both Embecta Corp and Rapport Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Embecta Corp and Rapport Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Embecta Corp and Rapport Therapeutics Common, you can compare the effects of market volatilities on Embecta Corp and Rapport Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Embecta Corp with a short position of Rapport Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Embecta Corp and Rapport Therapeutics.
Diversification Opportunities for Embecta Corp and Rapport Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Embecta and Rapport is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Embecta Corp and Rapport Therapeutics Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics and Embecta Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Embecta Corp are associated (or correlated) with Rapport Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics has no effect on the direction of Embecta Corp i.e., Embecta Corp and Rapport Therapeutics go up and down completely randomly.
Pair Corralation between Embecta Corp and Rapport Therapeutics
Given the investment horizon of 90 days Embecta Corp is expected to under-perform the Rapport Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Embecta Corp is 2.89 times less risky than Rapport Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Rapport Therapeutics Common is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,327 in Rapport Therapeutics Common on October 18, 2025 and sell it today you would earn a total of 1,359 from holding Rapport Therapeutics Common or generate 102.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Embecta Corp vs. Rapport Therapeutics Common
Performance |
| Timeline |
| Embecta Corp |
| Rapport Therapeutics |
Embecta Corp and Rapport Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Embecta Corp and Rapport Therapeutics
The main advantage of trading using opposite Embecta Corp and Rapport Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Embecta Corp position performs unexpectedly, Rapport Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics will offset losses from the drop in Rapport Therapeutics' long position.| Embecta Corp vs. CareDx Inc | Embecta Corp vs. SIGA Technologies | Embecta Corp vs. Emergent Biosolutions | Embecta Corp vs. Aquestive Therapeutics |
| Rapport Therapeutics vs. Nurix Therapeutics | Rapport Therapeutics vs. Kodiak Sciences | Rapport Therapeutics vs. Phathom Pharmaceuticals | Rapport Therapeutics vs. Xencor Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |